Skip to content

5-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[(1R,3R)-3-methoxycyclopentyl]benzimidazol-2-yl]pyrrolidin-2-one

C22H26N4O3 — CID 154948466

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPAC5-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[(1R,3R)-3-methoxycyclopentyl]benzimidazol-2-yl]pyrrolidin-2-one
SMILESCO[C@@H]1CC[C@@H](n2c(C3CCC(=O)N3)nc3cc(-c4c(C)noc4C)ccc32)C1
InChIInChI=1S/C22H26N4O3/c1-12-21(13(2)29-25-12)14-4-8-19-18(10-14)24-22(17-7-9-20(27)23-17)26(19)15-5-6-16(11-15)28-3/h4,8,10,15-17H,5-7,9,11H2,1-3H3,(H,23,27)/t15-,16-,17?/m1/s1
InChIKeyGJYCOIUXSFCDQJ-YNPPLXCJSA-N
MW394.48 g/mol
LogP4.00
Rot. Bonds4

About 5-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[(1R,3R)-3-methoxycyclopentyl]benzimidazol-2-yl]pyrrolidin-2-one

5-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[(1R,3R)-3-methoxycyclopentyl]benzimidazol-2-yl]pyrrolidin-2-one (PubChem CID 154948466) has the molecular formula C22H26N4O3 and a molecular weight of 394.48 g/mol. Its IUPAC name is 5-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[(1R,3R)-3-methoxycyclopentyl]benzimidazol-2-yl]pyrrolidin-2-one.

Molecular Properties

Compound Name5-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[(1R,3R)-3-methoxycyclopentyl]benzimidazol-2-yl]pyrrolidin-2-one
PubChem CID154948466
Molecular FormulaC22H26N4O3
Molecular Weight394.48 g/mol
Exact Mass394.20
IUPAC Name5-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[(1R,3R)-3-methoxycyclopentyl]benzimidazol-2-yl]pyrrolidin-2-one
SMILESCO[C@@H]1CC[C@@H](n2c(C3CCC(=O)N3)nc3cc(-c4c(C)noc4C)ccc32)C1
InChIInChI=1S/C22H26N4O3/c1-12-21(13(2)29-25-12)14-4-8-19-18(10-14)24-22(17-7-9-20(27)23-17)26(19)15-5-6-16(11-15)28-3/h4,8,10,15-17H,5-7,9,11H2,1-3H3,(H,23,27)/t15-,16-,17?/m1/s1
InChIKeyGJYCOIUXSFCDQJ-YNPPLXCJSA-N
XLogP4.00
TPSA82.18 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds4
Heavy Atoms29
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500394.48
LogP ≤ 54.00
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Analyze 5-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[(1R,3R)-3-methoxycyclopentyl]benzimidazol-2-yl]pyrrolidin-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 5-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[(1R,3R)-3-methoxycyclopentyl]benzimidazol-2-yl]pyrrolidin-2-one?
The IUPAC name of 5-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[(1R,3R)-3-methoxycyclopentyl]benzimidazol-2-yl]pyrrolidin-2-one (CID 154948466) is 5-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[(1R,3R)-3-methoxycyclopentyl]benzimidazol-2-yl]pyrrolidin-2-one.
What is the SMILES notation for 5-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[(1R,3R)-3-methoxycyclopentyl]benzimidazol-2-yl]pyrrolidin-2-one?
The canonical SMILES for 5-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[(1R,3R)-3-methoxycyclopentyl]benzimidazol-2-yl]pyrrolidin-2-one is CO[C@@H]1CC[C@@H](n2c(C3CCC(=O)N3)nc3cc(-c4c(C)noc4C)ccc32)C1.
What is the InChIKey of 5-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[(1R,3R)-3-methoxycyclopentyl]benzimidazol-2-yl]pyrrolidin-2-one?
The InChIKey is GJYCOIUXSFCDQJ-YNPPLXCJSA-N. The full InChI is InChI=1S/C22H26N4O3/c1-12-21(13(2)29-25-12)14-4-8-19-18(10-14)24-22(17-7-9-20(27)23-17)26(19)15-5-6-16(11-15)28-3/h4,8,10,15-17H,5-7,9,11H2,1-3H3,(H,23,27)/t15-,16-,17?/m1/s1.
What are the key properties of 5-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[(1R,3R)-3-methoxycyclopentyl]benzimidazol-2-yl]pyrrolidin-2-one?
5-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[(1R,3R)-3-methoxycyclopentyl]benzimidazol-2-yl]pyrrolidin-2-one has a molecular weight of 394.48 g/mol, XLogP of 4.00, 4 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[(1R,3R)-3-methoxycyclopentyl]benzimidazol-2-yl]pyrrolidin-2-one is sourced from PubChem (CID 154948466), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.